+

WO2002005698A3 - Extraction de fluorophores a partir d'echantillons biologiques - Google Patents

Extraction de fluorophores a partir d'echantillons biologiques Download PDF

Info

Publication number
WO2002005698A3
WO2002005698A3 PCT/US2001/021981 US0121981W WO0205698A3 WO 2002005698 A3 WO2002005698 A3 WO 2002005698A3 US 0121981 W US0121981 W US 0121981W WO 0205698 A3 WO0205698 A3 WO 0205698A3
Authority
WO
WIPO (PCT)
Prior art keywords
fluorophores
extracting
biological samples
hepatitis
diseased
Prior art date
Application number
PCT/US2001/021981
Other languages
English (en)
Other versions
WO2002005698A2 (fr
Inventor
Omanand Koul
Victor S Sapirstein
Yongwu Yang
Original Assignee
Seroptix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seroptix Inc filed Critical Seroptix Inc
Priority to AU2001273404A priority Critical patent/AU2001273404A1/en
Publication of WO2002005698A2 publication Critical patent/WO2002005698A2/fr
Publication of WO2002005698A3 publication Critical patent/WO2002005698A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Cette invention concerne un procédé d'obtention d'un échantillon biologique pour la détection d'un état pathologique ou d'une infection tel que le VIH, l'hépatite A, l'hépatite B, l'hépatite C, seuls ou combinés. Ce procédé fait intervenir un liquide surnageant renfermant une dose détectable de composés libres, la présence desdits composés pouvant indiquer l'existence d'un état pathologique ou une infection.
PCT/US2001/021981 2000-07-13 2001-07-12 Extraction de fluorophores a partir d'echantillons biologiques WO2002005698A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001273404A AU2001273404A1 (en) 2000-07-13 2001-07-12 Method for extracting fluorophores from biological samples

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61636300A 2000-07-13 2000-07-13
US09/616,363 2000-07-13

Publications (2)

Publication Number Publication Date
WO2002005698A2 WO2002005698A2 (fr) 2002-01-24
WO2002005698A3 true WO2002005698A3 (fr) 2003-09-25

Family

ID=24469111

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/021981 WO2002005698A2 (fr) 2000-07-13 2001-07-12 Extraction de fluorophores a partir d'echantillons biologiques

Country Status (2)

Country Link
AU (1) AU2001273404A1 (fr)
WO (1) WO2002005698A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8240513B2 (en) 2008-03-24 2012-08-14 Fluid Management Operations Llc Fluid dispenser with nested displacement members

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5695756A (en) * 1990-08-31 1997-12-09 University Of Maryland At Baltimore Methods for treating hypertension
US6127115A (en) * 1995-11-14 2000-10-03 Ragland; William L. Efficient method of detecting an infectious agent in blood

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5695756A (en) * 1990-08-31 1997-12-09 University Of Maryland At Baltimore Methods for treating hypertension
US6127115A (en) * 1995-11-14 2000-10-03 Ragland; William L. Efficient method of detecting an infectious agent in blood

Also Published As

Publication number Publication date
WO2002005698A2 (fr) 2002-01-24
AU2001273404A1 (en) 2002-01-30

Similar Documents

Publication Publication Date Title
WO2002042486A3 (fr) Methodes de detection d'un acide nucleique par amplification sequentielle
EP0875584A3 (fr) Analyse des acides nucléiques
AU2001278452A1 (en) Method for the detection of influenza a/b viruses
WO2005021731A3 (fr) Detection et amplification d'analytes solubles
WO2001062982A3 (fr) Procedes destines a une amplification en phase solide en plusieurs etapes d'acides nucleiques
WO2003016552A3 (fr) Purification et recuperation d'adn a partir d'echantillons a haute teneur en particules et en solides
WO2001018252A3 (fr) Methodes de detection de maladies
WO2001036977A8 (fr) Procedes et compositions d'identification de marqueurs de maladie
WO2002090539A3 (fr) Compositions, methodes et trousses permettant d'isoler des acides nucleiques au moyen de tensioactifs et de proteases
WO2005059103A3 (fr) Plant de mais mon88017, compositions et procedes de detection associes
WO2001042502A3 (fr) Procedes de detection de maladies
WO2002044400A3 (fr) Compositions et techniques d'extraction d'acide nucleique
WO2002097132A3 (fr) Systeme de detection
IL157917A0 (en) Method for sample identification in a mammal as well as a kit for performing this method
ATE346958T1 (de) Universelles nachweissystem für mehrere varianten
WO2003002749A3 (fr) Procedes servant a detecter simultanement des antigenes de hcv et des anticorps anti-hcv
WO2002034951A3 (fr) Compositions et procedes de detection du virus de l'immunodeficience humaine 2 (vih-2)
WO2003054225A3 (fr) Procede de determination d'analytes du type acide nucleique
WO2004001418A3 (fr) Procede de detection et d'extraction d'endotoxines
NO20006109D0 (no) Analytisk metode som beskytter multippel virusmerking
WO2003048309A3 (fr) Polymerases d'acides nucleiques provenant de thermus thermophilus
WO2001059156A3 (fr) Detection de liaison d'especes chargees, au moyen de sondes sensibles au potentiel ou au ph
WO2002002055A3 (fr) Composes antifongiques et methodes d'utilisation
WO2002005698A3 (fr) Extraction de fluorophores a partir d'echantillons biologiques
ES2196870T3 (es) Procedimiento para la purificacion o aislamiento de acidos nucleicos virales.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载